Evidence map›Paper›PMID 42841205›Full record

ArticleCirculation research2026

Multimodality Molecular Profiling Nominates Targetable Mechanisms in Progressive RV Dysfunction.

Madelyn J Blake, Jenna B Mendelson, Jacob D Sternbach, Minwoo Kim, Rashmi M Raveendran, Ryan A Moon, Lynn M Hartweck, Walt Tollison, John P Carney, Todd Markowski and 4 more

Abstract read
In one paragraph

Article in Circulation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Madelyn J Blake *Gazes Cardiac Research Institute, Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston (M.J.B., S.E.P., K.W.P.)., University of Minnesota, Minneapolis.
Jenna B Mendelson *Department of Integrative Biology and Physiology (J.B.M.), University of Minnesota, Minneapolis.ORCID 0000-0002-8229-385X
Jacob D SternbachLillehei Heart Institute, Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis (J.D.S., M.K., R.M.R., R.A.M., L.M.H.).ORCID 0009-0009-2417-8261
Minwoo KimLillehei Heart Institute, Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis (J.D.S., M.K., R.M.R., R.A.M., L.M.H.).ORCID 0009-0001-2466-9804
Rashmi M RaveendranLillehei Heart Institute, Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis (J.D.S., M.K., R.M.R., R.A.M., L.M.H.).ORCID 0009-0001-4384-6036
Ryan A MoonLillehei Heart Institute, Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis (J.D.S., M.K., R.M.R., R.A.M., L.M.H.).
Lynn M HartweckLillehei Heart Institute, Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis (J.D.S., M.K., R.M.R., R.A.M., L.M.H.).ORCID 0000-0002-7926-3342
Walt TollisonExperimental Surgical Services, Department of Surgery (W.T., J.P.C.), University of Minnesota, Minneapolis.ORCID 0009-0005-1656-1480
John P CarneyExperimental Surgical Services, Department of Surgery (W.T., J.P.C.), University of Minnesota, Minneapolis.ORCID 0000-0002-2090-7764
Todd MarkowskiCenter for Metabolomics and Proteomics, Department of Biochemistry, Molecular Biology, and Biophysics (T.M., L.A.H.), University of Minnesota, Minneapolis.ORCID 0000-0001-9157-2036
LeeAnn HigginsCenter for Metabolomics and Proteomics, Department of Biochemistry, Molecular Biology, and Biophysics (T.M., L.A.H.), University of Minnesota, Minneapolis.ORCID 0009-0005-0286-5694
Sally E PrinsGazes Cardiac Research Institute, Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston (M.J.B., S.E.P., K.W.P.)., University of Minnesota, Minneapolis.
Felipe KazmirczakAllina Health Minneapolis Heart Institute, Abbott Northwestern Hospital, MN (F.K.).
Kurt W PrinsGazes Cardiac Research Institute, Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston (M.J.B., S.E.P., K.W.P.)., University of Minnesota, Minneapolis.ORCID 0000-0002-0364-6742

Funding

GP130 Antagonism in Porcine RV Pressure OverloadR01HL162927 · NHLBI · UNIVERSITY OF MINNESOTA · PI Kurt W Prins · 2022 to 2026
$3.3M
Multi-scale Investigation of Sex Differences in Right Ventricular Function via Estrogen-Microtubule InteractionsR01HL158795 · NHLBI · UNIVERSITY OF MINNESOTA · PI Kurt W Prins · 2022 to 2026
$2.8M
Mechanisms of Large Animal RV DysfunctionF31HL170585 · NHLBI · UNIVERSITY OF MINNESOTA · PI MENDELSON, JENNA BLAIR · 2024 to 2025
$71k
NHLBI NIH HHS F31 HL170585NHLBI NIH HHS R01 HL158795NHLBI NIH HHS R01 HL162927
6 · The paper itself

Abstract

backgroundRight ventricular dysfunction (RVD) is a robust predictor of mortality in multiple cardiovascular diseases. Currently, it remains unclear whether the severity of RVD corresponds to distinct cellular and molecular alterations, and this has important implications for defining optimal therapeutic targets. To address this knowledge gap, we performed a multiomic evaluation of pulmonary artery banded pigs with differing degrees of right ventricular (RV) compromise.

methodsPulmonary artery banded pigs were stratified into mild and severe RVD groups based on RV ejection fraction (mild RVD, 38±4%; severe RVD, 20±8%). RV tissue from control, mild RVD, and severe RVD animals was analyzed using single-nucleus RNA sequencing, mitochondrial and cytoplasmic proteomics, and phosphoproteomics. Histological analyses corroborated multiomic findings.

resultsCardiac magnetic resonance imaging revealed progressive structural and functional alterations in mild and severe RVD pigs. Single-nucleus RNA sequencing demonstrated that advancing RVD was associated with loss of cardiomyocytes, accumulation of efferocytosis-impaired macrophages, and dysregulated endothelial cells and pericytes. Combined transcriptomic and proteomic analyses showed escalating impairments of complex cardiomyocyte metabolism with worsening RVD. RV microvasculature was compromised with severe RVD as there were alterations in endothelial cell/pericyte genetic regulation, colocalization patterns in RV sections, and increased cardiomyocyte HIF1A (hypoxia-inducible factor 1 alpha) transcript expression. Analysis of both mitochondrial and global proteostasis revealed greater compromise in mitochondrial proteostasis, including downregulation of mitochondrial proteases, chaperones, and ribosomes. Paradoxically, cytoplasmic ribosomes were upregulated in severe RVD. The predicted kinome and phosphatome were uniquely altered in mild RVD as compared with severe RVD. Finally, integration of multiomic approaches identified activation of the ribotoxic stress response, impaired macrophage efferocytosis, and insufficient mitochondrial unfolded protein response as potential contributors to severe RVD. Multispecies comparison suggested that the ribotoxic stress response was the most conserved pathogenic response in RVD.

conclusionsOur multiomic analysis defines the cellular and molecular landscape of progressive RVD and nominates druggable pathways that may promote progressive RVD. Future studies are needed to determine how engaging these pathways influences RV phenotypes.

Indexed as

animalscardiomyocytesphosphoproteinsright ventricular dysfunctionvascular remodeling

Identifiers

PMID42841205
PMCPMC13647276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.